Literature DB >> 34950300

High Brain Natriuretic Peptide Level Predicts The Prevalence Of Low-Voltage Areas And Poor Rhythm Outcome In Patients Undergoing Atrial Fibrillation Ablation.

Yasuhiro Matsuda1, Masaharu Masuda1, Mitsutoshi Asai1, Osamu Iida1, Shin Okamoto1, Takayuki Ishihara1, Kiyonori Nanto1, Takashi Kanda1, Takuya Tsujimura1, Shota Okuno1, Yosuke Hata1, Hiroyuki Uematsu1, Toshiaki Mano1.   

Abstract

BACKGROUNDS: The prevalence of residual left atrial low-voltage areas (LVAs) is associated with atrial fibrillation (AF) recurrence after pulmonary vein isolation. Brain natriuretic peptide (BNP) may be increased in AF patients and may raise AF recurrence risk after catheter ablation. We investigated the association between BNP and the prevalence of LVAs.
METHODS: One hundred and eighty three consecutive AF cases were retrospectively enrolled that underwent initial ablation for AF (persistent AF, 82 [45%] patients). Serum BNP was measured before ablation and the natural logarithm of BNP (log-BNP) was calculated. Low-voltage points were defined as sites with left atrial electrogram amplitude <0.5 mV. LVAs were defined as regions with ≥5% low-voltage points across the total surface area of the left atrium.
RESULTS: Of the 183 patients, 38 (21%) had LVAs. Patients with LVAs demonstrated higher log-BNP (4.8±0.9 vs. 3.9±1.2, P<0.001). The optimal cut-off value of log-BNP was 4.4, which was equivalent to 81 pg/mL of BNP. LVAs were more frequent in patients with higher log-BNP. In multivariate analysis, log-BNP >4.4 was an independent predictor of LVAs (odds ratio 2.7 [95% confidence interval 1.01-7.1], P=0.048). Freedom from AF recurrence was significantly lower in patients with than without high log-BNP (P=0.007).
CONCLUSIONS: BNP correlated with the prevalence of left atrial LVAs and AF recurrence in patients with AF undergoing catheter ablation.

Entities:  

Keywords:  Atrial fibrillation; Brain natriuretic peptide; Catheter ablation; Low-voltage areas; Substrate

Year:  2020        PMID: 34950300      PMCID: PMC8691330          DOI: 10.4022/jafib.2279

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  19 in total

1.  Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation.

Authors:  Sascha Rolf; Simon Kircher; Arash Arya; Charlotte Eitel; Philipp Sommer; Sergio Richter; Thomas Gaspar; Andreas Bollmann; David Altmann; Carlos Piedra; Gerhard Hindricks; Christopher Piorkowski
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08-23

2.  Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

Authors:  K Maeda; T Tsutamoto; A Wada; T Hisanaga; M Kinoshita
Journal:  Am Heart J       Date:  1998-05       Impact factor: 4.749

3.  Comparison of electrogram waveforms between a multielectrode mapping catheter and a linear ablation catheter.

Authors:  Masaharu Masuda; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujimura; Yasuhiro Matsuda; Shota Okuno; Aki Tsuji; Toshiaki Mano
Journal:  Pacing Clin Electrophysiol       Date:  2019-03-25       Impact factor: 1.976

Review 4.  Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure.

Authors:  M Yoshimura; H Yasue; H Ogawa
Journal:  Can J Physiol Pharmacol       Date:  2001-08       Impact factor: 2.273

5.  Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score.

Authors:  Jedrzej Kosiuk; Borislav Dinov; Jelena Kornej; Willem-Jan Acou; Robert Schönbauer; Lukas Fiedler; Piotr Buchta; Krzysztof Myrda; Mariusz Gąsior; Lech Poloński; Simon Kircher; Arash Arya; Philipp Sommer; Andreas Bollmann; Gerhard Hindricks; Sascha Rolf
Journal:  Heart Rhythm       Date:  2015-07-02       Impact factor: 6.343

6.  Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.

Authors:  Masaharu Masuda; Masashi Fujita; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujimura; Yasuhiro Matsuda; Shota Okuno; Takuya Ohashi; Aki Tsuji; Toshiaki Mano
Journal:  Int J Cardiol       Date:  2018-04-15       Impact factor: 4.164

7.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

8.  Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Chia-Ying Liu; Yuan-Chang Liu; Colin Wu; Anderson Armstrong; Gustavo J Volpe; Rob J van der Geest; Yongmei Liu; William G Hundley; Antoinette S Gomes; Songtao Liu; Marcelo Nacif; David A Bluemke; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2013-07-17       Impact factor: 24.094

9.  Electrophysiologic and electroanatomic changes in the human atrium associated with age.

Authors:  Peter M Kistler; Prashanthan Sanders; Simon P Fynn; Irene H Stevenson; Steven J Spence; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

10.  Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

Authors:  Robert S Oakes; Troy J Badger; Eugene G Kholmovski; Nazem Akoum; Nathan S Burgon; Eric N Fish; Joshua J E Blauer; Swati N Rao; Edward V R DiBella; Nathan M Segerson; Marcos Daccarett; Jessiciah Windfelder; Christopher J McGann; Dennis Parker; Rob S MacLeod; Nassir F Marrouche
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.